Reduced infarct size in nonreperfused myocardial infarction by combined infusion of isosorbide dinitrate and streptokinase

American Heart Journal

Volumn 124, Issue 5, 1992, Pages 1139-1144

  Hildebrandt, Per ^a,b   Torp Pedersen, Christian ^a,b   Joen, Tomas ^a,b   Iversen, Elsebeth ^a,b   Jensen, Gunnar ^a,b   Jeppesen, Dorthe ^a,b   Melchior, Thomas ^a,b   Schytten, Hans Jørgen ^a,b   Ringsdal, Vibeke ^a,b   Jensen, Jytte ^a,b   Steensgaard Hansen, Frank ^a,b   Granborg, Jørgen ^a,b   Hassager, Christian ^a,b   Weiss, Marija ^a,b   Ermer, Wolfgang ^a,b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b Schwarz Pharma AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CREATINE KINASE; ISOSORBIDE DINITRATE; PLACEBO; STREPTOKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CREATINE KINASE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; INFUSIONS, INTRAVENOUS; ISOENZYMES; ISOSORBIDE DINITRATE; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; STREPTOKINASE; THROMBOLYTIC THERAPY;

EID: 0026490351     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(92)90392-9     Document Type: Article

References (28)

1. A Report of the American College of Cardiology/American Heart Association Task Force. ACC/AHA guidelines for the early management of patients with acute myocardial infarction
2. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase
3. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
4. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17 183 cases of suspected acute myocardial infarction: ISIS-2
5. Randomized trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1
6. Reduction of infarct size with the early use of timolol in acute myocardial infarction
7. Diltiazem and reinfarction in patients with non Q-wave myocardial infarction
8. Beneficial effect of intravenous nitroglycerin on haemodynamics and enzymatically estimated infarct size
9. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion and complications
10. Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin
11. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials
12. Comparison of two immunoinhibitory methods with agarose gelelectrophoresis for measuring the MB isoenzyme of creatine kinase in serum from cases of suspected myocardial infarction
13. Estimation of acute myocardial infarct size in man by serum CK-MB measurements
14. Indices of reperfusion in patients with acute myocardial infarction using characteristics of the CK-MB time-activity curve
15. Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction
16. Calculating confidence intervals for some non-parametric analyses. Statistics with confidence
17. Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the second Mount Sinai-New York University Reperfusion Trial
18. Myocardial salvage by intravenous nitroglycerin in conscious dogs: loss of beneficial effect with marked nitroglycerin-induced hypotension
19. Serum enzymes and myocardial infarct size: the effect of drugs
20. Comparison of different pharmacological interventions on enzymatic parameters during acute myocardial infarction
21. Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin
22. Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction
23. Persistent reduction in left ventricular asynergy in patients with acute myocardial infarction by intravenous infusion of nitroglycerin
24. Effects of nitroglycerin in therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction
25. Intermittent coronary occlusion in acute myocardial infarction
26. Heamodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction
27. Oral ISDN for the treatment of patients with acute myocardial infarction
28. Isosorbide dimitrate sublingual therapy for inferior myocardial infarction: randomized trial to assess infarct size limitation